Evommune
IPONovel Therapies for Chronic Inflammatory Disease
Public · Redwood City, United States · Founded 2020 · $172.5M raised
- Headquarters
- Redwood City, California
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- evommune.com
- Total Funding
- $172.5M
- Last Round
- $115.0M Series COct 2024
- Rounds
- 3
- Type
- Public
About
Clinical-stage biopharma developing novel therapies for immune-mediated chronic inflammatory diseases including atopic dermatitis.
Summary
Evommune is a Biotech company based in Redwood City, United States, founded in 2020. It has raised $172.5M in total across 3 rounds, most recently a $115.0M Series C round in Oct 2024. Investors include RA Capital Management, Arix Bioscience and Sectoral Asset Management.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...